PharmaBiome, a pre-clinical stage spinoff from the ETH Zurich, has developed unique technologies to access the entire range of intestinal bacteria for the design and production of function-based consortia at scale.
We met Christophe Lacroix, Founder of Pharmabiome, during the fourth edition of Microbiome Movement Drug Development Europe held in London.
Latest related content
Via Podgora 12/A, 20122, Milan, Italy – VAT: IT05299040963
© ALL RIGHTS RESERVED
This communication is only intended for business-to-business and health care professionals.
This communication is not intended for consumers of final consumer goods.
Nothing on this page is meant to be perceived as an approved claim.
